Erratum: Active surveillance strategies for low-grade prostate cancer: Comparative benefits and cost-effectiveness (Radiology (2021) DOI: 10.1148/radiol.2021204321)

Stella K. Kang, Rahul D. Mali, Vinay Prabhu, Bart S. Ferket, Stacy Loeb

Research output: Contribution to journalComment/debate

Abstract

Figure 1 contained an error. In Strategy 3 in the Rising MRI, True Negative/False Negative row, the box should read No Biopsy. Figure 4 contained an error and a footnote was added that clarified the following: Severity as determined by providers, given wide variability in life expectancy across types of comorbid conditions. Reflects patients with life expectancy of at least 10 years.

Original languageEnglish
Pages (from-to)E380
JournalRadiology
Volume301
Issue number1
DOIs
StatePublished - Oct 2021

Fingerprint

Dive into the research topics of 'Erratum: Active surveillance strategies for low-grade prostate cancer: Comparative benefits and cost-effectiveness (Radiology (2021) DOI: 10.1148/radiol.2021204321)'. Together they form a unique fingerprint.

Cite this